Ramachandran, Dhanya http://orcid.org/0000-0001-8139-7799
Tyrer, Jonathan P.
Kommoss, Stefan
DeFazio, Anna
Riggan, Marjorie J. http://orcid.org/0000-0002-3701-8031
Bowtell, David
Fereday, Sian
Traficante, Nadia
Hung, Jillian
Webb, Penelope M. http://orcid.org/0000-0003-0733-5930
Fasching, Peter A.
Lambrechts, Diether
García, María J.
Rodríguez-Antona, Cristina http://orcid.org/0000-0001-8750-7338
Goodman, Marc T.
Modugno, Francesmary
Moysich, Kirsten B.
Karlan, Beth Y. http://orcid.org/0000-0002-9451-2933
Lester, Jenny
Kjaer, Susanne K.
Jensen, Allan
Høgdall, Estrid
Goode, Ellen L.
Cliby, William A.
Kumar, Amanika
Wang, Chen
Cunningham, Julie M.
Winham, Stacey J.
Monteiro, Alvaro N. http://orcid.org/0000-0002-8448-4801
Schildkraut, Joellen M.
Cramer, Daniel W.
Terry, Kathryn L.
Titus, Linda
Bjorge, Line
Thomsen, Liv Cecilie Vestrheim
Friedlander, Michael
Obermair, Andreas
Grant, Peter
Beesley, Vanessa
Blomfield, Penelope
Brand, Alison
Davis, Alison
Leung, Yee
Nicklin, James
Quinn, Michael
Livingstone, Karen
O’Neill, Helen
Williams, Merran
Pejovic, Tanja
Høgdall, Claus K.
McNeish, Iain A.
May, Taymaa
Huntsman, David G.
Pfisterer, Jacobus
Canzler, Ulrich
Park-Simon, Tjoung-Won
Schröder, Willibald
Belau, Antje
Hanker, Lars
Harter, Philipp
Sehouli, Jalid
Kimmig, Rainer
de Gregorio, Nikolaus
Schmalfeldt, Barbara
Baumann, Klaus
Hilpert, Felix
Burges, Alexander
Winterhoff, Boris
Schürmann, Peter
Speith, Lisa-Marie
Hillemanns, Peter
Berchuck, Andrew
Johnatty, Sharon E.
Ramus, Susan J.
Chenevix-Trench, Georgia
Pharoah, Paul D. P. http://orcid.org/0000-0001-8494-732X
Dörk, Thilo http://orcid.org/0000-0002-9458-0282
Heitz, Florian http://orcid.org/0000-0002-2412-0352
,
,
Article History
Received: 14 June 2023
Accepted: 15 January 2024
First Online: 5 March 2024
Competing interests
: U.C. received honoraria for lectures from Lilly and AstraZeneca and is on the advisory board of AstraZeneca. J.P. received honoraria from Roche Pharma AG, AstraZeneca, Amgen, Clovis Oncology, MSD Oncology, GSK, Chugai Pharma, Teva, Medupdate, SAI MedPartners, Decision Resources, Simon-Kucher and partners, Juniper, Bionest partners, Vox Bio, Axiom healthcare strategies, Prosapient, iMed Institut, Lilly, and is a consultant/advisor for AstraZeneca, Roche, Pharma AG, Tesaro, Clovis Oncology, MSD Oncology. P.A.F. conducts research funded by Amgen, Novartis and Pfizer and received Honoraria from Roche, Novartis and Pfizer. None of these sponsors had any role in the design, data acquisition or interpretation of results in the present study.